(Q43845680)

27 November 2017

Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in Stage III non-small-cell lung cancer (English)

1 reference

27 November 2017

1 reference

1 reference

2

Yung Jue Bang

1 reference

27 November 2017

7

Cheolwon Suh

1 reference

27 November 2017

Hong Gyun Wu

1

1 reference

27 November 2017

Eun Kyung Choi

3

1 reference

27 November 2017

Yong Chan Ahn

4

1 reference

27 November 2017

Young Whan Kim

5

1 reference

27 November 2017

Tae Hwan Lim

6

1 reference

27 November 2017

Keunchil Park

8

1 reference

27 November 2017

Charn Il Park

9

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

International Journal of Radiation Oncology Biology Physics

27 November 2017

1 reference

27 November 2017

52

1 reference

27 November 2017

1

1 reference

27 November 2017

75-80

1 reference

Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901739-4

7 January 2021

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901739-4

7 January 2021

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901739-4

7 January 2021

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901739-4

7 January 2021

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901739-4

7 January 2021

Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901739-4

7 January 2021

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901739-4

7 January 2021

Taxol stabilizes microtubules in mouse fibroblast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901739-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901739-4

1 reference

7 January 2021

Phase I study of docetaxel with concomitant thoracic radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901739-4

7 January 2021

Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901739-4

7 January 2021

Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901739-4

7 January 2021

Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2801%2901739-4

7 January 2021

10.1016/S0360-3016(01)01739-4

Identifiers

DOI

1 reference

27 November 2017

1 reference